Almost Family Inc (AFAM) 35.46 $AFAM Davita's Expenses

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Almost Family Inc (AFAM) 35.46 $AFAM

Davita's Expenses Continue to Rise: Time to Dump the Stock?
Zacks Equity Research - Zacks Investment Research - Mon Sep 19, 9:23AM CDT
On Sep 19, we issued an updated research report on DaVita Inc. (DVA).
USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), DVA: 63.60 (-0.84), RDNT: 7.20 (+0.21)

Becton, Dickinson (BDX) Gets USFDA Clearance for BD MAX
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 9:29AM CDT
Becton, Dickinson and Company (BDX) recently announced that it got the clearance for its proprietary BD MAX CT/GC/TV assay from the U.S. Food and Drug Administration.
BDX: 175.66 (+0.46), USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), RDNT: 7.20 (+0.21)

BioScrip Buys Home Solutions, Strengthens Infusion Business
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 9:06AM CDT
BioScrip, Inc. (BIOS) has completed the acquisition of home infusion and home nursing products and services business Home Solutions.
USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), RDNT: 7.20 (+0.21), BIOS: 2.92 (+0.17)

AmSurg Expands in Anesthesiology, Enters South California
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 6:22AM CDT
Sheridan ??? the Physician Services Division of AmSurg Corp. (AMSG) ??? acquired Ambulatory Anesthesia Associates, Inc. and Genesis Anesthesia Services, Inc.
AMSG: 65.04 (-0.42), USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), RDNT: 7.20 (+0.21)

Almost Family, Inc. Testified Before U.S. Congress on How to Improve Post-Acute Care
GlobeNewswire - Thu Sep 08, 5:39PM CDT
CEO and Chairman of the Board of Almost Family, Inc. William Yarmuth announced today that Steve Guenthner, President of the Company, testified yesterday, September 7, before the U.S. House Ways & Means Health Subcommittee on payment reforms in post-acute settings.
AFAM: 35.46 (-0.34)

BioScrip's Deal with Home Solutions Revised, To Close Soon
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 5:07AM CDT
BioScrip (BIOS) recently amended the earlier terms of the agreement to acquire the Home Solutions business of HS Infusion Holdings, Inc.
USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), RDNT: 7.20 (+0.21), BIOS: 2.92 (+0.17)

Can Almost Family (AFAM) Stock Continue to Grow Earnings?
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 7:50AM CDT
One company that might be well-positioned for future earnings growth is Almost Family Inc. (AFAM)
AFAM: 35.46 (-0.34)

Is Almost Family an Incredible Value Stock? 3 Reasons Why AFAM Will Be Tough to Beat
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 7:36AM CDT
Almost Family (AFAM) is looking impressive and might be the best for value investors in the near term.
AFAM: 35.46 (-0.34)

Almost Family (AFAM) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:07AM CDT
Almost Family Inc. (AFAM) has been struggling lately, but the selling pressure may be coming to an end soon
AFAM: 35.46 (-0.34)

Quest Diagnostics' Sonora Quest Opens PSCs at Safeway
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:12AM CDT
Sonora Quest Laboratories of Quest Diagnostics (DGX), has recently opened six new Patient Service Centers (PSCs) at Safeway stores in Arizona.
USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), RDNT: 7.20 (+0.21), DGX: 83.28 (+0.03)

Addus HomeCare (ADUS) in Focus: Stock Up 8.2% in Session
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:45AM CDT
Addus HomeCare Corporation (ADUS) was a big mover last session, as the company saw its shares rise over 8% on the day.
AFAM: 35.46 (-0.34), ADUS: 24.77 (+0.06)

Quest Diagnostics: Strategic Initiatives & Tie-ups to Add Value
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:43AM CDT
On Aug 23, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), RDNT: 7.20 (+0.21), DGX: 83.28 (+0.03)

China Cord Blood (CO) Looks Good: Stock Adds 5.5% in Session
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 7:00AM CDT
China Cord Blood Corporation (CO) was a big mover last session, as the company saw its shares rise over 5% on the day.
AFAM: 35.46 (-0.34), CO: 5.39 (+0.04)

DaVita (DVA) Continues to Underperform: Time to Offload it?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:53AM CDT
On Aug 17, 2016, we issued an updated research report on DaVita HealthCare Partners Inc. (DVA)
USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), DVA: 63.60 (-0.84), RDNT: 7.20 (+0.21)

BioScrip (BIOS) Posts Strong Q2, Strategic Plans on Track
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 1:07PM CDT
On Aug 12, 2016, we issued an updated research report on BioScrip, Inc. (BIOS).
USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), RDNT: 7.20 (+0.21), BIOS: 2.92 (+0.17)

AAC Holdings (AAC) Worth a Look: Stock Up 6.9% in Session
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 7:45AM CDT
AAC Holdings, Inc. (AAC) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
AFAM: 35.46 (-0.34), AAC: 17.78 (+0.28)

BioScrip's (BIOS) Q2 Loss Narrower than Expected, Sales Top
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 11:09AM CDT
BioScrip, Inc. (BIOS) reported adjusted net loss from continuing operations of 8 cents per share in the second quarter of 2016.
ARA: 18.79 (-0.48), USPH: 63.78 (-0.16), AFAM: 35.46 (-0.34), BIOS: 2.92 (+0.17)

The Zacks Analyst Blog Highlights: PCM, CRA International, ICF International, Almost Family and Town Sports International Holdings
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:30AM CDT
The Zacks Analyst Blog Highlights: PCM, CRA International, ICF International, Almost Family and Town Sports International Holdings
CLUB: 3.35 (+0.06), AFAM: 35.46 (-0.34), PCMI: 18.32 (+0.10), ICFI: 43.95 (+0.40), CRAI: 26.47 (-0.09)

5 Stocks to Buy on Encouraging Employment Data
Swarup Gupta - Zacks Investment Research - Mon Aug 08, 7:31AM CDT
Employment data for the U.S. continued to be bullish for the second successive month in July.
CLUB: 3.35 (+0.06), PCMI: 18.32 (+0.10), AFAM: 35.46 (-0.34), ICFI: 43.95 (+0.40), CRAI: 26.47 (-0.09)

Amedisys (AMED) Down 5% Despite Q2 Earnings and Revenue Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:15AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 42 cents per share in the second quarter of 2016.
AMSG: 65.04 (-0.42), AFAM: 35.46 (-0.34), BIOS: 2.92 (+0.17), AMED: 49.24 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the $2.7 Billion Bid for Papa John’s: An Investment Insight

Updated Category News Views 229

Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...

Continue Reading
Key Highlights from Octopus Apollo VCT plc AGM Results

Updated Category News Views 105

Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...

Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance

Updated Category News Views 104

Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...

Continue Reading
Epinephrine Market Growth Insights and Future Potential

Updated Category News Views 112

Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...

Continue Reading
Canadian North Resources Achieves Major Milestones in Q2 2025

Updated Category News Views 183

Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....

Continue Reading